News | January 03, 2024
WuXi XDC partners with IntoCell to accelerate ADC discovery and development
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Sirius JV will be owned 51% by Sirius and 49% by Adani
Marks remarkable acceleration in innovation using AI technology
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Expands patient reach to remotest towns by furthering investment in GoApptiv
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Subscribe To Our Newsletter & Stay Updated
